Julie Wondolowski
Medical · Enfield, CTNPI 1205857000
Payments from drug & device makers
Across 83 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$324
- Pfizer$193
- Novo Nordisk$193
- Lilly USA, LLC$173
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$132
- Abbott$99
- plus $645 from 19 others
What the payments were for
- Food & beverage$1,759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $324 |
| Pfizer | 12 | $193 |
| Novo Nordisk | 10 | $193 |
| Lilly USA, LLC | 8 | $173 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $132 |
| Abbott | 5 | $99 |
| Sunovion Pharmaceuticals Inc. | 3 | $77 |
| AstraZeneca | 4 | $56 |
| Novartis | 3 | $55 |
| Boehringer Ingelheim | 3 | $54 |
| Almatica Pharma LLC | 2 | $51 |
| Scilex Pharmaceuticals Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $41 |
| Exact Sciences | 2 | $40 |
| Corium, LLC | 3 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| GSK | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Covis Pharma GmbH | 1 | $18 |
| Amgen | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$1,759 in reported general payments places this provider in the 75th percentile of 592 medical providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 50 | $496 |
| Escitalopram Oxalate | 31 | $396 |
| Lisinopril | 33 | $395 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $386 |
| Doxycycline Hyclate | 45 | $321 |
| Metoprolol Succinate | 15 | $268 |
| Losartan Potassium | 33 | $264 |
| Rosuvastatin Calcium | 15 | $222 |
| Levothyroxine Sodium | 15 | $210 |
| Omeprazole | 15 | $197 |
| Amlodipine Besylate | 25 | $122 |
| Gabapentin | 13 | $111 |
| Prednisone | 61 | $108 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $79 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other medical in Enfield
- Nicole MisiaszekEnfield$14K
- Kelly MeadEnfield$10K
- Jared MarshallEnfield$8K
- Shilpa DesaiStamford$215K
- Gregory RauNew Haven$211K
- John JasinskiNorwalk$185K
- Brianna PaesanoStamford$153K
- Debra SullivanDerby$100K
- Ryan DonovanNew Haven$75K
- Jonica PagnuccoWaterbury$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.